Hypotensive effect of endothelin-1 via endothelin-B-receptor pathway on pulmonary circulation is enhanced in rats with pulmonary hypertension

Journal of Cardiovascular Pharmacology

Volumn 36, Issue 5 SUPPL. 1, 2000, Pages

  Sakai, S ^a   Miyauchi, T ^a   Hara, J ^a   Goto, K ^a   Yamaguchi, I ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Endothelin (ET); Endothelin receptor; Endothelin receptor antagonist; Pulmonary hypertension

Indexed keywords

3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; BMS 193884; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; MONOCROTALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY DILATATION; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; HYPOTENSION; LUNG ARTERY PRESSURE; LUNG CIRCULATION; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; SYSTOLIC BLOOD PRESSURE;

EID: 0033761186     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200036001-00106     Document Type: Article

References (17)

1. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
2. Endothelin, a potent vasoconstrictor, is a vascular smooth muscle mitogen
3. Molecular and cellular mechanism of endothelin regulation. Implications for vascular function
4. Cloning and expression of a cDNA encoding an endothelin receptor
5. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor
6. Abundance of endothelin-3 in rat intestine, pituitary gland and brain
7. Increased plasma endothelin-1 in pulmonary hypertension: Marker or mediator of disease?
8. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension
9. Increased lung endothelin-1 production in rats with idiopathic pulmonary hypertension
10. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension
11. Pulmonary hypertension caused by congestive heart failure is ameliorated by long-term application of an endothelin receptor antagonist. Increased expression of endothelin-1 messenger ribonucleic acid and endothelin-1-like immunoreactivity in the lung in congestive heart failure in rats
12. Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats
13. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure. Marked increase in endothelin-1 production in the failing heart
14. Distribution of endothelin-1 in the lung of rats with pulmonary hypertension of different etiology
15. Level of ETB receptor mRNA is down-regulated by endothelins through decreasing the intracellular stability of mRNA molecules
16. Binding and receptor down-regulation of a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells
17. Inhibitors of endothelin